North American Pharmaceutical Contract Manufacturing Market Research and Forecast 2018-2023

North American Pharmaceutical Contract Manufacturing Market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2018-2023

The major players operating in the pharmaceutical industry consider outsourcing of the product manufacturing to contract manufacturing organizations. The contract manufacturers provide timely and cost-effective services, which in turn, enable the market players to focus on their core competencies. A pharmaceutical contract manufacturer offers comprehensive services to the clients ranging from drug development to the packaging of the products. Some of the services offered by contract manufacturers to their clients can be divided into two main categories: primary manufacturing and secondary manufacturing. The primary manufacturing mainly involves the synthesis of the bulk active pharmaceutical ingredients (API) however, the secondary manufacturing includes the formulation of bulk drug substances into the final drug products such as pills, topical formulations, and types of injectables. Major factors contributing to the growth of the North American pharmaceutical contract manufacturing market include increasing trend of outsourcing of healthcare services. In addition, patent cliff is another significant factor contributing in the market growth. The ongoing patent expiry of many blockbuster drugs coupled with decreasing profit margins on branded drugs, is forcing most healthcare companies to outsource manufacturing to control costs. Additionally, patent cliffs have cut sales revenue of many branded medications and forced drug makers to consider outsourcing manufacturing to enable control production costs. However, stringent government regulations hinder the market growth. Moreover, rising demand for low cost services and increasing drug discovery is expected to fuel the market growth in the near future.

Browse full report at: North American Pharmaceutical Contract Manufacturing Market

The North American pharmaceutical contract manufacturing market can be segmented on the basis of category, type, product, and services. On the basis of category, the market is divided as human-based drugs and animals-based drugs. Based on type, the market is segmented into sterile manufacturing and non-sterile manufacturing. Based on the product, the market is bifurcated into OTC drugs, API, finished dosage forms include solid dose, liquid dose and injectable dose, and others such as nutritional products and packaging. Based on the services, the market is sub-divided as manufacturing services, non-clinical services and research and development. Among services, manufacturing segment is expected to be the highest revenue generating segment owing to growing medical device manufacturing.

The North American pharmaceutical contract manufacturing market is further analyzed on the basis of the geographical regions that are contributing significantly towards the growth of the market. The market is analyzed according to the different countries as the US, Canada, Mexico and rest of North America. The US has major share in the North American healthcare and life science market due to the increasing healthcare expenditure that fuels the pharmaceutical contract manufacturing.

Some of the players operating in the North American pharmaceutical contract manufacturing market are AbbVie Inc., Confab Laboratories Inc., Catalent Inc., Allegiant Healthcare Inc., Baxter International Inc., and several others. In order to sustain in the competitive market, these players adopt various strategies such as merger & acquisitions, expansions, joint ventures and product development and partnership and collaboration. For instance, Catalent Inc., in April 2018, announced to invest $5 million in the innovative drug development center of excellence (CoE) at its New Jersey facility. The investment is focused on preclinical to clinical phase 2b formulation, analytical, and manufacturing solutions for orally delivered small molecules.

For related reports please visit: Pharmaceuticals Industry